Coronary Heart Disease With Asthma

Embed Size (px)

Citation preview

  • 7/31/2019 Coronary Heart Disease With Asthma

    1/31

  • 7/31/2019 Coronary Heart Disease With Asthma

    2/31

    Mr. JV, a 67 year old retired plumber, has

    recently moved to you area and has come

    to the pharmacy to collect his first

    prescription. He has a PMH of coronary

    heart disease (CHD) and has recently hada coronary stent inserted. The patient is

    also suffering from asthma and dyspepsia.

  • 7/31/2019 Coronary Heart Disease With Asthma

    3/31

  • 7/31/2019 Coronary Heart Disease With Asthma

    4/31

    For Coronary Heart Disease:Coronary artery disease decreases blood supply to the

    heart from the blocked coronary artery. The lower bloodflow may fail to meet the heart's demand for oxygen.

    Treatment aims to balance blood supply to the heart w/

    heart oxygen demand, & prevent worsening of coronary

    heart disease. Treatment of coronary artery disease ishighly individual, and must be based on a patient's

    symptoms and diagnostic test results.

  • 7/31/2019 Coronary Heart Disease With Asthma

    5/31

    For Asthma:

    Treatment of asthma has 2 aims: (a) relief of

    symptoms, (b) reduction of airways inflammation.

  • 7/31/2019 Coronary Heart Disease With Asthma

    6/31

  • 7/31/2019 Coronary Heart Disease With Asthma

    7/31

  • 7/31/2019 Coronary Heart Disease With Asthma

    8/31

  • 7/31/2019 Coronary Heart Disease With Asthma

    9/31

    ASPIRIN

    Alcohol may increase risk of GI ulceration and prolong

    bleeding time. Corticosteroids may decrease aspirin level. Decreased antihypertensive effect of beta-blockers.

    Unexpected hypotension may occur with nitroglycerin.

  • 7/31/2019 Coronary Heart Disease With Asthma

    10/31

    BETA-BLOCKER

    Calcium channel blockers can lower of blood pressure& heart rate to dangerous levels when administered

    together with metoprolol. Verapamil will cause increase of blood plasma level of

    either drug. It is important to monitor cardiacfunction due to additive effects.

    May cause shortness of breath in asthmatic.

  • 7/31/2019 Coronary Heart Disease With Asthma

    11/31

    NITROGLYCERIN (NITRATES)

    Possible additive hypotensive effect when used

    concomitantly w/ -blockers, antihypertensives. Aspirin may enhance vasodilatory and hemodynamic

    effects of nitroglycerin. Calcium Channel blocker: Symptomatic orthostatic

    hypotension may occur. Since alcohol also may intensify the blood pressure

    lowering effect of nitroglycerin, patients receiving

    nitroglycerin should be advised to drink alcoholic

    beverages with caution.

  • 7/31/2019 Coronary Heart Disease With Asthma

    12/31

    CALCIUM CHANNEL BLOCKERS

    Beta-blockers: May result in increased hypotension

    resulting to bradycardia, peripheral edema, CHF, AV

    block and asystole because of additive depressant

    effects on myocardial contractility or AV contraction.

  • 7/31/2019 Coronary Heart Disease With Asthma

    13/31

    STATINS

    Consumption of grapefruit or grapefruit juice inhibits

    the metabolism of statinsfuranocoumarins in

    grapefruit juice inhibit the cytochrome P450 enzyme

    CYP3A4, which is involved in the metabolism of most

    statins.

    Elevate function test (ALT, EST) Headache and dyspepsia frequently occur. Virapamil (Ca channel blocker) may increase risk of

    myopathy and rhabdomyolysis. Dont exceed 20 mg

    of statin

  • 7/31/2019 Coronary Heart Disease With Asthma

    14/31

    BETA 2-AGONIST

    -blockers:Pulmonary effects of salmeterol may be

    blocked and may produce severe bronchospasm in

    patient with COPD. -blockers precipitate

    bronchospasm and increase the dose of B-agonist

    necessary to achieve bronchodilation.

  • 7/31/2019 Coronary Heart Disease With Asthma

    15/31

    CORTICOSTEROID

    May increase risk of GI distress and bleeding.

    Use together cautiously.

    May decrease salicylate level. Monitor patientfor lack of salicylate effectiveness.

  • 7/31/2019 Coronary Heart Disease With Asthma

    16/31

    PROTON PUMP INHIBITORS

    No known interaction with other medication taken

  • 7/31/2019 Coronary Heart Disease With Asthma

    17/31

    Aspirin:

    Take 75-325 mg once daily.

    Beta-Blockers (Metoprolol):

    Maintenance: 100-200 mg daily. Can be combined

    w/ other antihypertensive.

  • 7/31/2019 Coronary Heart Disease With Asthma

    18/31

    Nitroglycerin (Gen-Nitro (Sublingual tablet)):

    (Oral) 0.3 to 0.6 mg dissolved under the tongue or

    in buccal pouch at first sign of acute angina attack;

    repeat q 5 min (do not exceed 3 tabs in 15 min). Also

    may be used as a single dose 5 10 min beforeactivity that might precipitate an angina attack.

  • 7/31/2019 Coronary Heart Disease With Asthma

    19/31

    Calcium channel blocker (Verapamil):

    (Oral) 40 160 mg tid. Do not exceed 480 mg/day.

    Statins (Simvastatin):

    Initial dose: 20 mg & may be adjusted at intervals of

    not

  • 7/31/2019 Coronary Heart Disease With Asthma

    20/31

    Beta 2-agonist (Salmeterol):

    (Inhalationtn) 1 inhalation (50mcg) bid, approx 12 hr

    apart.

    Corticosteroid (Prednisolone):

    5 60 mg/day

    Esomeprazole:

    The dose for preventing NSAID-induced ulcers is

    20 to 40 mg daily up to 6 months.

  • 7/31/2019 Coronary Heart Disease With Asthma

    21/31

    ASPIRIN:

    Avoid drinking alcohol. Alcohol may increase your risk

    of stomach bleeding.

    Instruct patient to take drug with food or after meals &w/ full glass of water to reduce unpleasant GI reaction. Instruct patient to report ringing in ears or unusual

    bleeding, bruising, or persistent GI pain.

  • 7/31/2019 Coronary Heart Disease With Asthma

    22/31

    -BLOCKERS:

    toprolol may worsen the symptoms of heart failure inme patients. Check with your doctor right away if you

    having chest pain or discomfort; dilated neck veins;

    treme fatigue; irregular breathing; an irregular heartbeatortness of breath; swelling of the face, fingers, feet, orer legs; weight gain; or wheezing.

    e this drug with meals.not stop abruptly.

  • 7/31/2019 Coronary Heart Disease With Asthma

    23/31

    -BLOCKERS:

    medicine may cause changes in your blood sugar levelsmedicine may cause some people to become less alertn they are normally.

  • 7/31/2019 Coronary Heart Disease With Asthma

    24/31

    NITROGLYCERIN:

    Advise patient that headaches are a common sideeffect of therapy and are also a marker of antianginal

    effectiveness. Caution patient not to crush, chew, or swallow

    sublingual tablets. Advise patient to discontinue nitroglycerin and notify

    healthcare provider if vision blurring and dry mouth

    occurs. Advise patient that stopping drug abruptly causes

    spasm of the coronary arteries.

  • 7/31/2019 Coronary Heart Disease With Asthma

    25/31

    CALCIUM CHANNEL BLOCKER:

    Tell patient if dose is missed to take as soon as

    possible. If several hours have passed or if nearing

    time for next dose, tell patient not to double dose to

    catch up unless advised by healthcare provider. Advise patient that drug may cause dizziness and to

    use caution while driving or performing other tasks

    requiring mental alertness until effect of drug have

    stabilized.

  • 7/31/2019 Coronary Heart Disease With Asthma

    26/31

    CALCIUM CHANNEL BLOCKER:

    Tell patient to swallow whole, do not cut, crush or

    chew. May cause nausea, headache, vomiting, dizziness,

    depression, constipation, irregular heartbeat,swelling of hands and feet.

  • 7/31/2019 Coronary Heart Disease With Asthma

    27/31

    STATINS:

    Advise patient to control weight and to adhere to

    prescribed dietary regimen. Instruct patient to report the following symptoms to

    healthcare provider: any unexplained muscle pain,tenderness, or weakness, especially if accompanied

    by fever or malaise; yellowing of skin or eyes. Take drug in the evening. Have periodic blood test.

  • 7/31/2019 Coronary Heart Disease With Asthma

    28/31

    BETA 2-AGONIST (INHALATION):

    If rash and urticaria, appears which signal a

    hypersensitivity reaction, patient should inform

    prescriber. Instruct patient not to stop the medication once

    symptoms have been controlled. Continued daily

    use is necessary to continue control of symptoms. Use only twice a day or as instructed. May occur headache, tremors, fast heart and

    palpitations.

  • 7/31/2019 Coronary Heart Disease With Asthma

    29/31

    CORTICISTEROID:

    Instruct patient to take medication with meals or snack

    to avoid GI irritation.

    Caution patient not to take with aspirin unless directedwith health care provider.

  • 7/31/2019 Coronary Heart Disease With Asthma

    30/31

    PPI:

    Instruct patient to take each dose on an empty

    stomach at least 1 hr before eating. Tell your doctor immediately if you have: heartburn

    combined with lightheadedness/ sweating/dizziness,chest pain or shoulder/jaw pain (especially with trouble

    breathing), pain spreading to arms/neck/shoulders,

    unexplained weight loss.

  • 7/31/2019 Coronary Heart Disease With Asthma

    31/31